A detailed history of 22 Nw, LP transactions in Psychemedics Corp stock. As of the latest transaction made, 22 Nw, LP holds 274,418 shares of PMD stock, worth $664,091. This represents 0.79% of its overall portfolio holdings.

Number of Shares
274,418
Previous 274,418 -0.0%
Holding current value
$664,091
Previous $812,000 0.99%
% of portfolio
0.79%
Previous 0.59%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$3.66 - $5.05 $1 Million - $1.39 Million
274,418 New
274,418 $1.09 Million
Q1 2021

May 14, 2021

SELL
$4.95 - $7.7 $373,893 - $581,611
-75,534 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$3.67 - $5.1 $367 - $509
-100 Reduced 0.13%
75,534 $384,000
Q3 2020

Nov 13, 2020

SELL
$4.33 - $6.05 $26,421 - $36,917
-6,102 Reduced 7.47%
75,634 $334,000
Q2 2020

Aug 14, 2020

BUY
$4.9 - $6.14 $266,246 - $333,623
54,336 Added 198.31%
81,736 $454,000
Q1 2020

May 15, 2020

BUY
$4.63 - $10.62 $126,862 - $290,988
27,400 New
27,400 $166,000

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $13.6M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track 22 Nw, LP Portfolio

Follow 22 Nw, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 22 Nw, LP, based on Form 13F filings with the SEC.

News

Stay updated on 22 Nw, LP with notifications on news.